Bayesian Capital Management’s Zimmer Biomet ZBH Stock Holding History

Bayesian Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12,500	Closed	-$1.23M	–	566
2025 Q3	$1.23M	Buy	+12,500	New	+$1.24M	0.25%	123
2025 Q1	–	Sell	-26,607	Closed	-$2.81M	–	1015
2024 Q4	$2.81M	Buy	26,607 +22,900	+618%	+$2.46M	0.34%	83
2024 Q3	$400K	Buy	+3,707	New	+$405K	0.05%	422
2023 Q3	–	Sell	-20,700	Closed	-$3.01M	–	1059
2023 Q2	$3.01M	Buy	20,700 +7,400	+56%	+$1.01M	0.32%	65
2023 Q1	$1.72M	Buy	13,300 +6,226	+88%	+$782K	0.21%	135
2022 Q4	$902K	Buy	+7,074	New	+$821K	0.13%	210
2022 Q3	–	Sell	-9,359	Closed	-$983K	–	1058
2022 Q2	$983K	Buy	+9,359	New	+$1.11M	0.18%	155
2021 Q3	–	Sell	-6,065	Closed	-$947K	–	580
2021 Q2	$947K	Buy	+6,065	New	+$982K	0.25%	108
2020 Q4	–	Sell	-3,193	Closed	-$422K	–	693
2020 Q3	$422K	Sell	3,193 -2,472	-44%	-$323K	0.1%	265
2020 Q2	$656K	Sell	5,665 -6,180	-52%	-$712K	0.14%	199
2020 Q1	$1.16M	Sell	11,845 -6,489	-35%	-$851K	0.25%	95
2019 Q4	$2.66M	Buy	18,334 +11,330	+162%	+$1.56M	0.46%	41
2019 Q3	$933K	Sell	7,004 -3,811	-35%	-$492K	0.18%	161
2019 Q2	$1.24M	Buy	+10,815	New	+$1.27M	0.26%	110
2019 Q1	–	Sell	-11,845	Closed	-$1.19M	–	792
2018 Q4	$1.19M	Sell	11,845 -1,545	-12%	-$174K	0.24%	121
2018 Q3	$1.71M	Buy	+13,390	New	+$1.59M	0.28%	88
2016 Q4	–	Sell	-5,070	Closed	-$640K	–	726
2016 Q3	$640K	Buy	+5,070	New	+$626K	0.42%	74
2016 Q1	–	Sell	-6,308	Closed	-$628K	–	453
2015 Q4	$628K	Buy	+6,308	New	+$617K	0.9%	9

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Bayesian Capital Management's ZBH Position: Q4 2025 in Review

Bayesian Capital Management sold out of Zimmer Biomet (ZBH) in Q4 2025, closing a stake of 12,500 shares — an estimated $1.23M sold.

Bayesian Capital Management first reported a position in ZBH in Q4 2015 and held it in 18 quarters. The position peaked at $3.01M in Q2 2023. 949 funds tracked by Wall St. Rank hold ZBH as of Q4 2025.

Bayesian Capital Management reported no remaining Zimmer Biomet position as of Q4 2025 after selling out during the quarter.
Bayesian Capital Management sold 12,500 Zimmer Biomet shares in Q4 2025, an estimated $1.23M.
Bayesian Capital Management first reported a position in Zimmer Biomet in Q4 2015 and held it in 18 quarters.
Bayesian Capital Management's Zimmer Biomet position peaked at $3.01M in Q2 2023.
949 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.